Healthtech Startups

Phenomics Health builds a medication-response intelligence platform that combines high-complexity clinical laboratory testing, pharmacogenomics, pharmacometabolomics, and AI-enabled analytics to support precision prescribing and medication decisions. It serves clinicians, payors, providers, and life-sciences partners in the precision-medicine space.

1 investor

PhenoML provides enterprise-grade APIs that convert clinical text into normalized medical codes and structured FHIR data for HIPAA-regulated healthcare workflows. It serves providers, health tech companies, and biopharma with use cases including EHR integration, referral intake, medical billing/coding, prior authorization, and patient record summarization.

1 investor

PhenoTap develops KetoTap Core, a patent-pending BHB oxidase enzyme designed for reliable, affordable, real-time ketone measurement in blood test strips and continuous monitors. It offers the enzyme as a drop-in technology for device makers building glucose-style sensors, targeting continuous ketone monitoring for health and therapeutic applications.

1 investor

Phibodent is an industrial manufacturer of dental restorations, producing CAD-CAM structures in chrome-cobalt and titanium as well as custom bite splints for dental laboratories and clinics. It also offers a cloud platform for digital prescription and management of dental treatments, with an international presence.

1 investor

Phigenics provides water management and Legionella prevention solutions for healthcare and institutional facilities. The company has over 20 years of experience helping organizations ensure water safety and regulatory compliance.

1 investor

Philia Medical Editions is a French medical publishing group that produces specialist medical and dental journals, books, congress reports, and digital publications for physicians and dentists. Founded in 2012, it also provides health communication tools and press relations services across three areas: specialized medicine, dental medicine, and health communication.

1 investor

Philogen discovers and develops targeted anti-cancer biopharmaceutical drugs using monoclonal antibodies and small molecules for tumor-specific delivery. The company focuses on vascular targeting to deliver therapeutic agents to tumors while sparing healthy tissues.

1 investor

Phi Med Europe develops NerveCheck, a portable medical device for early diagnosis and quantification of peripheral neuropathy, particularly diabetic neuropathy, using quantitative sensory testing (QST) technology. The device delivers rapid, non-invasive assessment of small and medium nerve fiber function for healthcare professionals in clinical settings.

1 investor

Phlebot develops medical devices for blood collection and diagnostics, with a focus on pediatric and intensive care applications. The company is advising on intellectual property, regulatory, and legal services related to FDA compliance for life sciences products.

1 investor

Phlex65 offers on-demand elder care by matching seniors and their families with vetted caregivers, with flexible scheduling from a few hours up to 24-hour coverage. Its platform handles onboarding, scheduling, logging, tracking, monitoring, and payment settlement for care services.

1 investor

Phluence develops an AI-powered multiagent platform that automates and optimizes patient support workflows for pharmaceutical companies, including enrollment, case management, benefit verification, and market access functions. The platform serves pharma manufacturers managing complex patient services operations around reimbursement, clinical education, and financial assistance.

1 investor

Phoenix provides customized health and safety training courses for organizations, including both tailored versions of existing courses and bespoke courses built to client specifications. The company adapts course content to match industry requirements and organizational branding.

1 investor

Phoenix PharmaLabs is a pharmaceutical company that welcomes inquiries from organizations seeking business relationships and potential opportunities.

1 investor

Phoenix SENOLYTIX develops gene therapies targeting senescent cells to address aging-related conditions. The company utilizes its ApoptiCIDe-CE™ platform technology, validated in human patients, to eliminate unwanted cells in the body.

1 investor

Phoenix Kinetics develops the NUsurface meniscus implant, a device that preserves knee motion and provides pain relief for patients with early knee osteoarthritis who fall between meniscal allograft transplantation and total knee replacement. The company targets an estimated U.S. patient population of over one million and has run clinical trials demonstrating pain reduction and improved physical function.

1 investor

PhorMed develops next-generation therapies targeting inflammation-driven diseases, particularly rare oncological conditions, using AI-powered targeting technology. The company serves patients with inflammatory and cancer-related diseases, focusing on improving efficacy and safety of first-line treatments.

1 investor

PhotonPharma develops riboflavin and UV-based treatment technology (disposables and equipment) optimized for cancer immunotherapy and vaccine production. The company works with Colorado State University's School of Biomedical Engineering and external consultants to advance its immunotherapy platform.

1 investor

Photon Sports develops technology for measuring athletic performance and preventing injuries through optical system analysis. The company serves athletes, trainers, and sports organizations seeking data-driven physical performance optimization.

1 investor

PhotoQ3 is a research and development company developing gentle treatment methods for diseases that currently lack cures. Its stated mission is to contribute to patients and society through these therapies.

1 investor

1 investor

Phyla produces skincare products for acne-prone skin, including a pH-balancing gel cleanser that removes excess oil without irritation. The company focuses on microbiome-conscious formulations recommended by dermatologists.

1 investor

PhysAct provides a physical activity and stress management service designed to address mental health and wellbeing issues in the workplace. The company targets businesses and organizations seeking to reduce employee stress, improve productivity, and lower healthcare costs through structured physical activity programs guided by physiotherapists.

1 investor

Physicians Services Group (PSG) is a group of physicians and nurse practitioners that provides attending and medical director services to Skilled Nursing Facilities. It delivers post-acute care across specialties such as geriatrics, cardiology, and wound care, currently serving patients in South Carolina.

1 investor

Physician Assist provides AI-powered medical scribing services that use ambient AI to capture clinical conversations and convert them into medical notes, and to support billing accuracy. It serves healthcare providers and physicians across the United States.

1 investor